Consequently, some authors consider GLP-1 RAs to be safe in the IBD population, however, they emphasise the necessity of providing educational advice to patients (e.g
The MHRA's Yellow Card scheme (yellowcard.mhra.gov.uk) has received some reports of anxiety-related symptoms with semaglutide products, though causality has not been definitively established
Cardiovascular Health : Research indicates that GLP-1 receptor agonists may have cardioprotective effects , improving heart health by regulating lipid levels , reducing inflammation , and improving vascular function
Age-related differences in outcomes Younger adults (18-40) typically achieve faster weight loss and greater total reductions compared to older adults (60+), though older individuals still achieve clinically meaningful results
This receptor activation reduces appetite, slows gastric emptying, and increases feelings of fullness after eating